RNS News

April has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, AdventHealth and DexCare both named new CEOs, and Crozer Health and UNC Health have undergone CEO exits. There were also layoffs at organizations including Aetna, Sanford Health and Caribou Biosciences. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News.

Regulus Therapeutics drug farabursen is a potential first-in-class treatment for a rare kidney disease whose only FDA-approved therapy introduces severe toxicity risks. Farabursen is joining a Novartis drug lineup spanning several therapies for rare renal disorders. The post Novartis Gets Phase 3-Ready Rare Kidney Disease Drug via $800M Regulus Acquisition appeared first on MedCity News.

Several states and insurers have gold carding programs to streamline prior authorization. However, some say they’re falling short. The post Gold Carding Programs Are Meant to Improve Prior Authorization. Are They Working? appeared first on MedCity News.

Emerging MRI research suggests that brain age is nearly two years older than chronological age for people with metabolic dysfunction-associated steatotic liver disease (MASLD) and increased alcohol intake.

Emerging MRI research suggests that brain age is nearly two years older than chronological age for people with metabolic dysfunction-associated steatotic liver disease (MASLD) and increased alcohol intake.